Mrs. Brenda Leanne Brown, MASTER OF SCIENCE Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 592 Highway 160, Fountain Hill, AR 71642 Phone: 870-940-0222 |
News Archive
BioMarin Pharmaceutical Inc. announced today that it has entered into a stock purchase agreement to acquire LEAD Therapeutics, Inc. (LEAD), a small private drug discovery and early stage development company with key compound LT-673, an orally available poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of patients with rare, genetically defined cancers.
Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,659,096 with claims that cover the use of amplification consumables in several current real-time and end point PCR instruments.
A drug developed to treat certain strains of cystic fibrosis may be useful in the treatment of chronic obstructive pulmonary disease, one of the most common lung diseases, which is seen frequently in smokers and has no cure. The findings were published online Friday, June 29, 2012 in the online journal PLoS ONE by researchers at the University of Alabama at Birmingham.
Researchers in France have hit on a novel method to help kidney stone sufferers ensure they receive the correct and most effective treatment possible.
For the first time, researchers have access to detailed information about how an urban Aboriginal population in Canada uses health care. A new study, called Our Health Counts, uses this health database to clearly demonstrate the unique challenges faced by urban Aboriginal people in Canada - according to researchers at St. Michael's Hospital.
› Verified 6 days ago